Sunday, May 09, 2021 9:27:53 PM
David Koos, chairman and chief executive of Regen said: "Because HemaXellerate is a personalized cell therapy product aimed at addressing an unmet medical need, we are in agreement with the FDA in performing the most rigorous safety and efficacy experiments in order to deliver this promising product to patients who at the moment have no other options."
This personalized approach is ""ROCKET SCIENCE""!!!!!!!!!!!!!!!!!!!!
Why??? WE have never had it before!!!! Because it utilizes a patients own DNA to establish a ""KILLER"" medicine using GENE Sequencing or gene Splicing of the patients own DNA.....A TaylorMade drug!!!! Messenger RNA and Gene Sequencing/Splicing of a persons own DNA to combat/fight illness is 21st Century medicine----
RGBP is a future big pharma's wet dream-----
cheers
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM